(Allergan plc)

	AGN latest price $303.9783 (-0.13%) ($303.1290 - $306.0341) on Thu. Jul. 23, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.31% (three month average)
RSI	60
Latest Price	$303.9783(-0.13%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.2% a day on average for past five trading days.
Weekly Trend	AGN advances 1.7% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(42%)    IVE(41%)
Factors Impacting AGN price	AGN will decline at least -0.655% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    UUP(-7%)    SHY(-6%)    IGOV(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.655% (StdDev 1.31%)
Hourly BBV	0 ()
Intraday Trend	-0.4%

5 Day Moving Average	$305.23(-0.41%)
10 Day Moving Average	$305.97(-0.65%)
20 Day Moving Average	$300.5(1.16%)
To recent high	-1.9%
To recent low	11.3%
Market Cap	$100.222b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed